Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,238.9
7.0 (0.22%)

 

  • STI Straits Times Index
    3,238.9
    7.0 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.8
    1.2 (0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,326.7
    3.0 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,891.3
    -18.5 (-0.64%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,303.3
    161.8 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,128.3
    29.4 (0.48%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,162.2
    22.9 (1.07%)
    Index delayed 20 minutes
  • XAO XAO
    6,898.9
    58.1 (0.85%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,681.9M
  • Value: 1,310.8M
  • Rise: 177
  • Fall: 153
  • Unch: 499

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.001-
United Engineers2.700-0.010
YZJ Shipbldg SGD1.000+0.030
SingTel3.180-0.120
Golden Agri-Res0.255+0.010
Rex Intl0.191-0.007
China Star Food0.030+0.002
Tritech0.032+0.003
Ascendas Reit2.890-0.010
Sino Grandness0.044-

World Indices

World Indices
Name Last Change
Nasdaq 8,540.8 +61.8
HSI 26,326.7 +3.0
HSCEI 10,424.8 -2.6
Jakarta 6,128.3 +29.4
Nikkei 225 23,303.3 +161.8
SSE Comp 2,891.3 -18.5
Shanghai A 3,029.3 -19.4
Shanghai B 255.2 -3.0
PSE Comp 0.0
KOSPI 2,162.2 +22.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MEGASUN MEGA SUN CITY HOLDINGS BERHAD
Quotes 15 Minutes Delayed. Updated at 15 Nov 2019 16:52
Last (MYR): 0.160 Change: -0.010 High: 0.165 Remarks:
Change (%): -5.88 Low: 0.160
Open 0.165 Yesterday's Close 0.170
Buy Price 0.160 Sell Price 0.165
Buy Volume ('00) 414 Sell Volume ('00) 759
Cumulative Volume ('00) 3,380 Cumulative Value 54,530
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.00418 Trailing EPS (MYR) e 0.00248 NAV (MYR) b 0.2700
PE a 38.278 Trailing PE f 64.435 Price / NAV b 0.5926
Dividend (MYR) d - Cash In Hand (MYR) g 0.0115 Issued & Paid-up Shares c 250,491,000
Dividend Yield (%) d - Price / Cash In Hand g 13.913 Treasury Shares h -
Beta - 75 Daysi 2.772 R-Squared - 75 Days(%)i 6.84 Market Cap (M) 40.079
Beta - 500 Daysi 0.315 R-Squared - 500 Days (%)i 0.13 Enterprise Value (M) 37.835
Piotroski F Score 4 Exchange Code 0081 Par Value ( MYR ) n.a.
52 Weeks Volatility (%) 57.03 6-Month VWAP 0.128 Free Float (%) -
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Biotechnology
Index Components BM INDUSTRIAL PRODUCTS & SERVICES / FBM ACE
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Jun 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 24 Jun 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MEGASUN Bursa 40.079 38.278 64.435 0.5926 -
Industry Biotechnology Bursa 333.964 22.339 19.335 1.7059 3.633
INDUSTRIAL SERVICES Bursa 156.456 34.504 31.609 1.0060 3.012
Index BM INDUSTRIAL PRODUCTS & SERVICES Bursa 714.328 21.706 31.422 1.5986 3.197
FBM ACE Bursa 122.534 1814.902 3125.929 1.3771 0.926
Local Peer DPHARMA Bursa 930.761 19.537 16.912 1.8478 3.911
Local Peer MGRC Bursa 31.053 - - 1.9493 -
Global Peer AMGEN INC NASDAQ 131,231.478 15.634 16.268 12.0099 2.533
Global Peer CSL ASX 124,695.694 46.478 46.478 16.6635 0.966
Global Peer GILEAD SCIENCES INC NASDAQ 82,323.311 15.091 30.569 3.9955 3.551
Global Peer CELGENE CORP NASDAQ 78,302.774 19.353 13.317 6.4783 -
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 53,950.070 25.735 25.166 10.2696 -
Global Peer BIOGEN INC NASDAQ 50,933.363 11.496 9.440 3.6392 -
Global Peer ILLUMINA INC NASDAQ 44,979.795 54.455 46.228 10.1329 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,865.336 15.491 17.659 3.6047 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,218.966 76.642 22.592 5.1020 0.783
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), BEIGENE (HKEx), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), Lonza (SGX), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), GENSCRIPT BIO (HKEx), SPARK THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), 3SBIO (HKEx), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NATERA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), AIMMUNE THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), VIELA BIO INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), FRONTAGE (HKEx), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), FATE THERAPEUTICS (NASDAQ), RADIUS HEALTH INC (NASDAQ), CKLIFE SCIENCES (HKEx), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), POLYNOVO LIMITED (ASX), OPKO HEALTH INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VIVA BIOTECH (HKEx), INTREXON CORP (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ASCENTAGE-B (HKEx), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), NEXTCURE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), INTELLIA THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), CORTEXYME INC (NASDAQ), SINOMAB BIO-B (HKEx), PRECISION BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), TRANSLATE BIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), RETROPHIN INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), MEIRAGTX HOLDINGS PLC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CHEMOCENTRYX INC (NASDAQ), XBIOTECH INC (NASDAQ), AGENUS INC (NASDAQ), KADMON HLDGS INC (NYSE), INTRA-CELLUAR THERAPIES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CYTOKINETICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ESSEX BIO-TECH (HKEx), MORPHIC HOLDING INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MERUS B V (NASDAQ), MACROGENICS INC (NASDAQ), AVROBIO INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), DERMIRA INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), MEDICINOVA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), TELIX PHARMACEUTIC (ASX), CASI PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PERSONALIS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ANAPTYSBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), NEXT SCIENCE LTD (ASX), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), KAMADA (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ATHERSYS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), PFENEX INC (NYSE American), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), JOUNCE THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), BBI LIFE SCI (HKEx), NABRIVA THERAPEUTICS PLC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ENZO BIOCHEM INC (NYSE), NANOVIRICIDES INC (NYSE American), UNI-BIO GROUP (HKEx), APTOSE BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), IVERIC BIO INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), FIVE PRIME THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), SESEN BIO INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CHIMERIX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PARATEK PHARMACEUTICALS INC (NASDAQ), IMUGENE LIMITED (ASX), NOVAVAX INC (NASDAQ), NANTKWEST INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PHYLOGICA LIMITED (ASX), AVEO PHARMACEUTICALS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), VTV THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), ADURO BIOTECH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), COHBAR INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ARAVIVE INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), OTONOMY INC (NASDAQ), VACCINEX INC (NASDAQ), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CEL-SCI CORP (NYSE American), SYNLOGIC INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFLARX N V (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ORTHOCELL LIMITED (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), CT ENTERPRISE (HKEx), INMUNE BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), PORT (SET), BELLICUM PHARMACEUTICALS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), BIONOMICS LTD (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOTRON (ASX), BIONANO GENOMICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), BIOSINO BIO-TEC (HKEx), BIOCARDIA INC (NASDAQ), MEMPHASYS LTD (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), RHINOMED LIMITED (ASX), ORAGENICS INC (NYSE American), ALIMERA SCIENCES INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), EXTRAWELL PHAR (HKEx), ISORAY INC (NYSE American), MICROBOT MEDICAL INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), AETERNA ZENTARIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), SENESTECH INC (NASDAQ), ANTEOTECH LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), IMMURON LIMITED (ASX), AEVI GENOMIC MEDIC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), VAXART INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CELLMID LIMITED (ASX), ATYR PHARMA INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), Suntar Eco-City^ (SGX), IBIO INC (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), PRECIPIO INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), TROVAGENE INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), OCUGEN INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HAO WEN HLDGS (HKEx), BIOXYNE LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), TRILLIUM THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TBG DIAGNOSTICS LTD (ASX), QT Vascular (SGX), MEDIBIO LIMITED (ASX), XENETIC BIOSCIENCES INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AIM IMMUNOTECH INC (NYSE American), NANOLLOSE LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.005
+3.23 %
10 Days --0.005
-3.03 %
20 Days -+0.040
+33.33 %
Medium Term Return 3 Months -+0.070
+77.78 %
6 Months -+0.050
+45.45 %
1 Year --0.010
-5.88 %
Long Term Return 2 Years --0.070
-30.43 %
3 Years --0.230
-58.97 %
5 Years --0.400
-71.43 %
Annualised Return Annualised --
-22.16 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.090 - 0.210 Change From 1 Year Low +0.070 % Change From 1 Year Low (%) +77.78
Change From 1 Year High -0.050 % Change From 1 Year High (%) -23.81
2 Years Range 0.090 - 0.260 Change From 2 Years Low +0.070 % Change From 2 Years Low (%) +77.78
Change From 2 Years High -0.100 % Change From 2 Years High (%) -38.46
5 Years Range 0.090 - 0.600 Change From 5 Years Low +0.070 % Change From 5 Years Low (%) +77.78
Change From 5 Years High -0.440 % Change From 5 Years High (%) -73.33
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Equator Life Science Berhad Group (Equator)was founded in 1997 as Yi Hup Agriculture Development Sdn Bhd.. Subsequently on 1999, it changed its name to Equator Biotech Sdn. Bhd. (EBSB), the company was listed on the Kuala Lumpur Mesdaq Board under the holding company Equator Life Science Berhad.

Equator Life Science Berhad (Equator) is principally engaged in propagation of various ornamental plants through the application of biotechnology. Equator was listed on the MESDAQ Board of Bursa Malaysia Securities Berhad on 25th May 2005.

Unlike traditional growers who cultivate plants through conventional methods, the Equator Group uses a combination of biotechnology technique such as micro propagation and bioconversion to mass propogate ornamental plants in order to isolate and retain the best characteristics of parent plants.

The fundamental of micro propagation is tissue or cell culture. Currently, Equator produces plants through tissue culture technique whilst cell culture is in an advantage stage of R&D. Besides improving the quality of plants, tissue ulture is also capable to mass propagate in a shorter time frame. The Equator Group has also commenced R&D in genetic engineering to create novel plants by manipulating genes.

IPO Performance

Listing Date 25 May 2005 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) -
IPO Price (MYR) 0.500 First Day Close (MYR) 0.300 First Week Close (MYR) 0.280
Current vs IPO Price (%) -68.00 First Day Gain (%) -40.00 First Week Gain (%) -44.00

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(1.36 MB)
Annual Report 2017 Dec 2017 Part 1(0.44 MB)
Part 2(1.28 MB)
Annual Report 2016 Dec 2016 Part 1(1.17 MB)
Annual Report 2015 Dec 2015 Part 1(2.37 MB)
Annual Report 2014 Dec 2014 Part 1(1.44 MB)
Annual Report 2013 Dec 2013 Part 1(0.90 MB)
Annual Report 2012 Dec 2012 Part 1(0.87 MB)
Annual Report 2011 Dec 2011 Part 1(0.77 MB)
Annual Report 2010 Dec 2010 Part 1(0.89 MB)
Annual Report 2009 Dec 2009 Part 1(0.77 MB)
Part 2(0.05 MB)
Annual Report 2008 Dec 2008 Part 1(0.77 MB)
Annual Report 2007 Dec 2007 Part 1(0.78 MB)
Annual Report 2006 Dec 2006 Part 1(2.05 MB)
Annual Report 2005 Dec 2005 Part 1(1.50 MB)
Annual Report 2004 Dec 2004 Part 1(1.61 MB)
Part 2(1.40 MB)
Part 3(0.01 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
15 Nov 2019 0.165 0.165 0.160 0.160 338,000 0.1613
14 Nov 2019 0.160 0.170 0.160 0.170 171,200 0.1626
13 Nov 2019 0.170 0.170 0.165 0.165 385,300 0.1666
12 Nov 2019 0.155 0.170 0.155 0.170 1,346,400 0.1627
11 Nov 2019 0.155 0.155 0.155 0.155 420,000 0.1550
08 Nov 2019 0.155 0.155 0.155 0.155 161,000 0.1550
07 Nov 2019 0.155 0.155 0.155 0.155 619,500 0.1550
06 Nov 2019 0.160 0.160 0.155 0.155 1,231,800 0.1563
05 Nov 2019 0.160 0.160 0.160 0.160 428,300 0.1600
04 Nov 2019 0.165 0.165 0.155 0.160 1,852,000 0.1604
01 Nov 2019 0.170 0.170 0.160 0.165 1,804,400 0.1647
31 Oct 2019 0.165 0.175 0.165 0.175 1,145,600 0.1681
30 Oct 2019 0.165 0.180 0.155 0.170 2,181,300 0.1698
29 Oct 2019 0.140 0.165 0.140 0.165 3,224,000 0.1516
25 Oct 2019 0.135 0.135 0.130 0.135 239,000 0.1344
24 Oct 2019 0.135 0.135 0.130 0.135 1,066,700 0.1314
23 Oct 2019 0.135 0.140 0.135 0.140 854,000 0.1382
22 Oct 2019 0.135 0.145 0.130 0.135 3,787,300 0.1396
21 Oct 2019 0.125 0.140 0.115 0.130 3,914,200 0.1293
18 Oct 2019 0.100 0.125 0.100 0.120 2,435,600 0.1170
17 Oct 2019 0.105 0.105 0.100 0.105 607,000 0.1009
16 Oct 2019 0.100 0.100 0.100 0.100 30,000 0.1000
Summary
Current 2 Weeks
(04 Nov 2019 to 15 Nov 2019)
0.165 0.170 0.155 0.160 6,953,500 -
Previous 2 Weeks
(18 Oct 2019 to 01 Nov 2019)
0.100 0.170 0.100 0.165 20,652,100 -
4 Weeks from
(20 Sep 2019 to 17 Oct 2019)
0.105 0.170 0.105 0.105 2,643,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.